- Providence Molecular Genomic Lab (MGL)
Using Scientific Insights to Redefine the Future of Care for All
Mission Focused Genomic Testing
Unique in our approach from commercial labs, we are driven by our “Health for a Better World” vision and use advanced genomic testing to improve care and access for all.
For Patients
Experience unmatched personalized care with  advanced testing insights that help to optimize care  from early detection, to risk evaluation, and targeted therapies.
For Providers
As a Providence in-house, system wide lab  we provide unrivalled diagnostic accuracy and insights from a full range of tests delivered with integrated, provider-centered support, Explore our state-of-the-art testing and broad panel choices.
A Providence-personized Lab Experience
AI-based Clinical Trial Matching
Advancing hope with AI-based clinical trial matching that connects patients to the most promising treatments.
System-wide Molecular Tumor Board
Ease complex case presentations with automated tumor board tools that make it easier to collaborate with systemwide experts in oncology, pathology, genomics, and other specialities.
Epic Workflows, and Helpful Colleagues
As your colleagues we’re available to quickly respond to lab and patient testing questions in detail. The MGL is integrated with MyChart and Epic, with supportive workflows that simplify ordering, reporting, alerting, and patient communication.
Your Support Advances Research-driven Innovation
Test ordering within Providence drives innovation. Specimen biobanking and MGL data sets help to build a Providence-strong culture that supports mission-aligned research to improve care for all.
“As genomic sequencing rapidly shifts into clinical practice, we are gathering evidence for widespread adoption while witnessing its transformative impact on real-life care decisions.”
Alipi V. Bonm, MD, PhD
Director, Neuro-Oncology, Swedish Neuroscience Institute